These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28520930)

  • 1. Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods.
    Svensson RJ; Gillespie SH; Simonsson USH
    J Antimicrob Chemother; 2017 Aug; 72(8):2311-2319. PubMed ID: 28520930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of Analysis Methods for Assessment of Pharmacodynamic Interactions Including Design Recommendations.
    Chen C; Wicha SG; Nordgren R; Simonsson USH
    AAPS J; 2018 Jun; 20(4):77. PubMed ID: 29931471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations.
    Clewe O; Wicha SG; de Vogel CP; de Steenwinkel JEM; Simonsson USH
    J Antimicrob Chemother; 2018 Feb; 73(2):437-447. PubMed ID: 29136155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Power to identify exposure-response relationships in phase IIa pulmonary tuberculosis trials with multi-dimensional bacterial load modeling.
    Koele SE; Dorlo TPC; Upton CM; Aarnoutse RE; Svensson EM
    CPT Pharmacometrics Syst Pharmacol; 2024 Mar; 13(3):374-385. PubMed ID: 38102814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multistate tuberculosis pharmacometric model: a semi-mechanistic pharmacokinetic-pharmacodynamic model for studying drug effects in an acute tuberculosis mouse model.
    Chen C; Ortega F; Rullas J; Alameda L; Angulo-Barturen I; Ferrer S; Simonsson US
    J Pharmacokinet Pharmacodyn; 2017 Apr; 44(2):133-141. PubMed ID: 28205025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and dose response of anti-TB drugs in rat infection model of tuberculosis.
    Kumar N; Vishwas KG; Kumar M; Reddy J; Parab M; Manikanth CL; Pavithra BS; Shandil RK
    Tuberculosis (Edinb); 2014 May; 94(3):282-6. PubMed ID: 24629633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
    Verbeeck RK; Günther G; Kibuule D; Hunter C; Rennie TW
    Eur J Clin Pharmacol; 2016 Aug; 72(8):905-16. PubMed ID: 27305904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs and alternative possibilities in the treatment of tuberculosis.
    Hofman S; Segers MM; Ghimire S; Bolhuis MS; Sturkenboom MG; Van Soolingen D; Alffenaar JW
    Expert Opin Emerg Drugs; 2016; 21(1):103-16. PubMed ID: 26848966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical modeling and systems pharmacology of tuberculosis: Isoniazid as a case study.
    Lalande L; Bourguignon L; Maire P; Goutelle S
    J Theor Biol; 2016 Jun; 399():43-52. PubMed ID: 27059890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of anti-tuberculosis drugs in Venezuelan children younger than 16 years of age: supportive evidence for the implementation of revised WHO dosing recommendations.
    Verhagen LM; López D; Hermans PW; Warris A; de Groot R; García JF; de Waard JH; Aarnoutse RE
    Trop Med Int Health; 2012 Dec; 17(12):1449-56. PubMed ID: 23094704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust Bayesian nonlinear mixed-effects modeling of time to positivity in tuberculosis trials.
    Burger DA; Schall R; Chen DG
    Pharm Stat; 2018 Sep; 17(5):615-628. PubMed ID: 30027676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the Multistate Tuberculosis Pharmacometric Model in Patients With Rifampicin-Treated Pulmonary Tuberculosis.
    Svensson RJ; Simonsson U
    CPT Pharmacometrics Syst Pharmacol; 2016 May; 5(5):264-73. PubMed ID: 27299939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the clinical pharmacology of tuberculosis medications.
    Egelund EF; Alsultan A; Peloquin CA
    Clin Pharmacol Ther; 2015 Oct; 98(4):387-93. PubMed ID: 26138226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?
    Lanoix JP; Chaisson RE; Nuermberger EL
    Clin Infect Dis; 2016 Feb; 62(4):484-90. PubMed ID: 26527614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico evaluation and exploration of antibiotic tuberculosis treatment regimens.
    Pienaar E; Dartois V; Linderman JJ; Kirschner DE
    BMC Syst Biol; 2015 Nov; 9():79. PubMed ID: 26578235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of food on the pharmacokinetics of first-line anti-TB drugs in treatment-naive TB patients: a randomized cross-over trial.
    Saktiawati AM; Sturkenboom MG; Stienstra Y; Subronto YW; Sumardi ; Kosterink JG; van der Werf TS; Alffenaar JW
    J Antimicrob Chemother; 2016 Mar; 71(3):703-10. PubMed ID: 26661397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerating clinical drug development for children with tuberculosis.
    Murray S; McKenna L; Pelfrene E; Botgros R
    Int J Tuberc Lung Dis; 2015 Dec; 19 Suppl 1():69-74. PubMed ID: 26564546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bedaquiline: a review of human pharmacokinetics and drug-drug interactions.
    van Heeswijk RP; Dannemann B; Hoetelmans RM
    J Antimicrob Chemother; 2014 Sep; 69(9):2310-8. PubMed ID: 24860154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm.
    Gumbo T; Pasipanodya JG; Nuermberger E; Romero K; Hanna D
    Clin Infect Dis; 2015 Aug; 61 Suppl 1():S18-24. PubMed ID: 26224768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.